Epidemiological characteristics of mumps in Guangxi, 2011-2019
10.3969/j.issn.1006-2483.2020.06.010
- VernacularTitle:2011—2019年广西流行性腮腺炎流行病学特征分析
- Author:
Jiagui CHEN
1
;
Jinfa DU
1
;
Rencong YANG
1
;
Qiuyun DENG
1
;
Aihu DONG
1
;
Jing LIU
1
;
Sha LI
1
;
Jianan WEI
1
;
Weicai LU
1
;
Gangyong PAN
1
Author Information
1. Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region, Nanning Guangxi 530028, China
- Publication Type:Journal Article
- Keywords:
Mumps;
Epidemiological characteristic;
Incidence
- From:
Journal of Public Health and Preventive Medicine
2020;31(6):42-45
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the epidemiological characteristics of mumps in Guangxi from 2011 to 2019, and to provide a scientific basis for formulating effective prevention and control strategies. Methods Descriptive epidemiological method was used to analyze the incidence data of mumps in Guangxi from 2011 to 2019. Results From 2011 to 2019, a total of 146,132 cases of mumps were reported in Guangxi, with an average annual incidence rate of 34.23 /100 000. There were 88,919 male cases (60.85%) and 57,213 female cases (39.15%). The incidence rate decreased from 62.26/100 000 in 2011 to 16.46/100 000 in 2015, and increased from 18.60/100 000 in 2016 to 46.90/100 000 in 2019. There were seasonal variations in the incidence, with the incidence peaks occurring from April to July and from October to the following January. 85.39% of cases were under 15 years of age, and 76.82% of cases were among kindergarteners or school children. A total of 228 mumps outbreaks were reported during 2011-2019,including 5,347 cases, accounting for 3.66% of the total cases. The incidence rates of mumps in Nanning (56.09/100 000), Hechi (48.26/100 000), Liuzhou (46.77/100 000), Baise (46.34/100 000) and Fangchenggang (40.68/100,000) were relatively higher than other places. Conclusion The mumps incidence is on an upward trend in Guangxi since 2015-2019, occurring mainly in older children or students. It is suggested to adhere to the second dose of mumps containing vaccine for kindergarten and school children and strengthen the surveillance and outbreak control of mumps in schools.